Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2003 | 03-2003 | |
| Operating Expenses | 3,479 | 2,810 |
| Operating Income | -3,479 | -2,810 |
| Other Income | 14 | 29 |
| Pre-tax Income | -3,465 | -2,781 |
| Net Income Continuous | -3,465 | -2,781 |
| Net Income | $-3,465 | $-2,781 |
| EPS Basic Total Ops | 125.96 | -643.81 |
| EPS Basic Continuous Ops | -626.96 | -503.20 |
| EPS Diluted Total Ops | -307.91 | -643.81 |
| EPS Diluted Continuous Ops | -303.42 | -503.20 |
| EBITDA(a) | $-3,391 | $-2,723 |